News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
213,131 Results
Type
Article (11982)
Company Profile (111)
Press Release (201038)
Section
Business (59820)
Career Advice (413)
Deals (9289)
Drug Delivery (21)
Drug Development (30826)
Employer Resources (43)
FDA (3745)
Job Trends (4876)
News (102002)
Policy (8160)
Tag
Academia (972)
Alliances (16787)
Alzheimer's disease (459)
Approvals (3740)
Artificial intelligence (53)
Bankruptcy (68)
Best Places to Work (4174)
Biotechnology (93)
Breast cancer (67)
Cancer (576)
Career advice (376)
CAR-T (56)
Cell therapy (183)
Clinical research (23167)
Collaboration (264)
Compensation (74)
COVID-19 (2178)
C-suite (77)
Cystic fibrosis (41)
Data (622)
Diabetes (44)
Diagnostics (1799)
Drug discovery (43)
Earnings (18795)
Events (44702)
Executive appointments (236)
FDA (3993)
Funding (200)
Gene editing (40)
Gene therapy (124)
GLP-1 (163)
Government (1600)
Healthcare (5302)
Infectious disease (2260)
Inflammatory bowel disease (53)
Interviews (53)
IPO (4663)
Job creations (905)
Job search strategy (338)
Layoffs (73)
Legal (1333)
Lung cancer (50)
Lymphoma (49)
Manufacturing (84)
Medical device (2249)
Medtech (2249)
Mergers & acquisitions (4795)
Metabolic disorders (126)
Neuroscience (584)
NextGen: Class of 2025 (1605)
Non-profit (1222)
Northern California (811)
Obesity (68)
Opinion (60)
Patents (52)
People (20803)
Phase I (8564)
Phase II (10853)
Phase III (6609)
Pipeline (275)
Postmarket research (575)
Preclinical (3989)
Press Release (54)
Radiopharmaceuticals (57)
Rare diseases (91)
Real estate (1885)
Regulatory (5743)
Research institute (827)
Resumes & cover letters (42)
Southern California (712)
Startups (1294)
United States (6621)
Vaccines (433)
Date
Today (61)
Last 7 days (227)
Last 30 days (947)
Last 365 days (13462)
2025 (947)
2024 (13574)
2023 (15078)
2022 (21221)
2021 (26949)
2020 (24461)
2019 (11269)
2018 (8686)
2017 (8750)
2016 (8375)
2015 (9434)
2014 (7256)
2013 (5915)
2012 (6449)
2011 (7131)
2010 (6527)
Location
Africa (299)
Asia (12485)
Australia (2768)
California (1808)
Canada (616)
China (104)
Colorado (47)
Connecticut (77)
Europe (28657)
Florida (220)
Illinois (146)
Indiana (99)
Maryland (278)
Massachusetts (1378)
Michigan (75)
Minnesota (88)
New Jersey (485)
New York (470)
North Carolina (313)
Northern California (811)
Ohio (60)
Pennsylvania (429)
South America (367)
Southern California (712)
Texas (252)
Virginia (51)
Washington State (299)
213,131 Results for "vir biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC
January 8, 2025
·
10 min read
Biotech Bay
Vir Biotechnology to Host 2024 Annual Meeting of Stockholders
Vir Biotechnology, Inc. (Nasdaq: VIR) today reminds stockholders that it will hold its 2024 Annual Meeting of Stockholders on Wednesday, May 29, 2024, at 9:00 a.m. PT.
May 23, 2024
·
1 min read
Press Releases
Vir Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
·
1 min read
Press Releases
Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference
November 25, 2024
·
1 min read
FDA
Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application and granted Fast Track designatio.
June 26, 2024
·
7 min read
Business
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
19 min read
Biotech Bay
Vir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical Officer
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Mark D. Eisner, M.D., M.P.H. will join the company as Executive Vice President and Chief Medical Officer (CMO), effective June 03, 2024.
May 29, 2024
·
5 min read
Biotech Bay
Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled to participate in a fireside chat at the BofA Securities Healthcare Conference 2024 on Tuesday, May 14, at 4:20 p.m. PT / 7:20 p.m. ET.
April 30, 2024
·
1 min read
Press Releases
Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta
December 12, 2024
·
7 min read
Press Releases
Vir Biotechnology to Host Virtual Investor Event on PRO-XTEN™ Masked T-Cell Engager Programs
November 26, 2024
·
4 min read
1 of 21,314
Next
